EGFR and lung carcinoma: An activating mutation in the activation loop of the EGFR kinase domain, L858R (also identified as Leu834 in a different numbering of the EGFR sequence) is among most frequent mutations in lung cancer, amounting to more than 40% of EGFR mutations in this cancer category [45]–[47].